Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New developments in panic disorder.

P C Marzol1, M H Pollack

  • 1Massachusetts General Hospital, 15 Parkman Street, WACC 815, Boston, MA 02114, USA.

Current Psychiatry Reports
|December 21, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Brain connectomics predict response to treatment in social anxiety disorder.

Molecular psychiatry·2015
Same author

The role of anxiety sensitivity in sleep disturbance in panic disorder.

Journal of anxiety disorders·2011
Same author

Nightmares among Cambodian refugees: the breaching of concentric ontological security.

Culture, medicine and psychiatry·2009
Same author

Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder.

Depression and anxiety·2009
Same author

A detailed examination of cytokine abnormalities in Major Depressive Disorder.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2007
Same journal

Child and Adolescent Psychiatry in the Far East: Findings from Multi-National Surveys.

Current psychiatry reports·2026
Same journal

Involuntary Celibacy in the Digital Age: a Critical Narrative Review of the Incel Phenomenon, Mental Health Burden, Ideological Pathways, and Public Health Implications.

Current psychiatry reports·2026
Same journal

Is Technology Remaking Therapy: The Screen and the Self: Telepsychiatry, AI Therapy, and the Defense Against Intimacy.

Current psychiatry reports·2026
Same journal

Bridging Gaps in Perinatal Mental Health: A Review of Peer and Non-specialist Supports for Racially, Ethnically and Culturally Diverse Communities in the U.S.

Current psychiatry reports·2026
Same journal

Psychosocial Preparedness for Disasters: A Scoping Review of International Models and Public Health Priorities.

Current psychiatry reports·2026
Same journal

Artificial Intelligence in Child and Adolescent Psychiatry: A Narrative Review of Recent Clinical Applications and Ethical Considerations.

Current psychiatry reports·2026
See all related articles

Panic disorder involves panic attacks and fear of future attacks, impacting daily life. Selective serotonin reuptake inhibitors are effective treatments for this condition.

Area of Science:

  • Psychiatry
  • Clinical Psychology

Background:

  • Panic disorder is a disabling condition marked by recurrent panic attacks and anticipatory anxiety.
  • It leads to avoidance behaviors and significant impairment in social, emotional, and vocational functioning.
  • Panic disorder is associated with high healthcare utilization.

Purpose of the Study:

  • To provide an overview of panic disorder.
  • To discuss its prevalence, healthcare utilization, quality of life impairment, and treatment options.

Main Methods:

  • This article reviews existing literature on panic disorder.
  • It synthesizes information on epidemiology, clinical impact, and therapeutic interventions.

Main Results:

  • Panic disorder significantly affects quality of life and functioning.

Related Experiment Videos

  • Pharmacologic agents and cognitive-behavioral therapies are effective treatments.
  • Selective serotonin reuptake inhibitors are increasingly used as first-line pharmacotherapy due to their efficacy and side effect profile.

    • Conclusions:

    • Effective treatments exist for panic disorder, including pharmacotherapy and cognitive-behavioral therapy.
    • Selective serotonin reuptake inhibitors represent a key pharmacologic approach.
    • Understanding the disorder's impact is crucial for effective management and improving patient outcomes.